Published: Tuesday 30 January 2018
A new multi-million Euro initiative funded by the European Commission has been set up to help prevent stroke in patients with existing conditions.
The Stroke Association is a member of the Stroke Alliance For Europe (SAFE) which is responsible for communicating this important research to the public.
The €6.9m project is aimed at patients with atrial fibrillation (AF), a common heart condition which causes an irregular and abnormally fast heartbeat, who have previously had a stroke caused by bleeding in the brain (termed intracerebral haemorrhage or ICH).
The Prevention of Stroke in intracerebral haemorrhage survivor with Atrial Fibrillation (PRESTIGE-AF) project brings together scientists and clinicians across Europe with the goal of reducing the risk of further stroke in this group of patients.
Stroke is one of the largest public health challenges around the world, and occur when the blood supply to the brain is interrupted, such as through a clot or a brain bleed.
It is the most common cause of adult-acquired disability, the second leading cause of death globally and the second most frequent cause of dementia. In addition, as stroke is a disease of the elderly, its impact is expected to further increase in the coming decades due to the ageing population.
The project will be led by Professor Roland Veltkamp from the Department of Medicine at Imperial College London and involves 11 other partner institutions throughout the UK.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 754517.